Sai Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 14, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	188,577	158,581	-	-	-	-
Enterprise Value	187,462	166,413	-	-	-	-
Last Close Price	902.90	760.85	-	-	-	-
PE Ratio	75.98	93.21	-	-	-	-
Forward PE	66.25	72.51	-	-	-	-
PS Ratio	9.87	9.36	-	-	-	-
PB Ratio	8.86	7.45	-	-	-	-
P/TBV Ratio	8.91	7.49	-	-	-	-
P/OCF Ratio	-	50.50	-	-	-	-
EV/Sales Ratio	9.81	9.82	-	-	-	-
EV/EBITDA Ratio	36.74	41.02	-	-	-	-
EV/EBIT Ratio	52.77	62.31	-	-	-	-
Debt / Equity Ratio	0.17	0.17	0.95	1.05	1.10	0.78
Debt / EBITDA Ratio	0.69	0.87	3.28	5.80	8.18	4.12
Debt / FCF Ratio	-	-	11.40	8.77	-	-
Asset Turnover	-	0.62	0.66	0.56	0.44	-
Inventory Turnover	-	4.51	4.27	3.50	3.04	-
Quick Ratio	-	1.12	1.05	0.93	0.99	1.05
Current Ratio	-	2.05	1.28	1.27	1.32	1.34
Return on Equity (ROE)	-	10.96%	8.89%	1.13%	0.71%	-
Return on Assets (ROA)	-	6.14%	4.83%	1.90%	0.98%	-
Return on Capital (ROIC)	-	7.61%	5.78%	2.25%	1.15%	-
Return on Capital Employed (ROCE)	-	11.00%	11.20%	4.60%	2.10%	7.10%
Earnings Yield	1.29%	1.07%	-	-	-	-
FCF Yield	-	-0.35%	-	-	-	-
Buyback Yield / Dilution	-12.26%	-8.04%	-0.27%	-0.46%	-5.32%	-

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.